• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿育吠陀饮食与生活方式对肠道微生物群的调节作用:关于其治疗2型糖尿病可能途径的综述

Modulation of gut microbiota with Ayurveda diet and lifestyle: A review on its possible way to treat type 2 diabetes.

作者信息

Chauhan Ashutosh, Semwal Deepak Kumar, Semwal Ruchi Badoni, Joshi Sunil Kumar, Adhana Rajesh Kumar, Goswami Madhavi Sanjay

机构信息

Department of Biotechnology, Faculty of Biomedical Sciences, Uttarakhand Ayurved University, Dehradun, Uttarakhand, India.

Department of Phytochemistry, Faculty of Biomedical Sciences, Uttarakhand Ayurved University, Dehradun, Uttarakhand, India.

出版信息

Ayu. 2022 Apr-Jun;43(2):35-44. doi: 10.4103/ayu.AYU_7_20. Epub 2023 Aug 2.

DOI:10.4103/ayu.AYU_7_20
PMID:37655174
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10468021/
Abstract

BACKGROUND

The prevalence of type 2 diabetes (T2D) has increased substantially in the past few decades throughout the world. In India, the epidemic of diabetes continues to increase irrespective of area, status, and age. Despite various scientific societies involved in the treatment of diabetes, still, the burden of diabetes keeps growing.

AIMS

The aim of this work is to explore the Ayurvedic concept of a personalized diet to modulate the gut microbiota for the treatment of T2D.

MATERIAL AND METHODS

A thorough study of literature from online scientific databases including Web of Science, PubMed, Scopus, and Google Scholar as well as from classical texts of Ayurveda was done. A careful compilation was done to extract the valuable output of the personalized diet to modulate the gut microbiota.

RESULTS

There are various diets used to control blood glucose levels, and their effects are also being studied on the transcriptome or epigenome despite 99.9% genomic similarity among human beings. However, microbiomes have only 10% similarity. Ayurvedic diet is given on the basis of (body constitution), therefore, it is also called personalized diet.

CONCLUSION

The diets prescribed for T2D in Ayurveda are high in fibers, polyphenols, and complex carbohydrates which enrich butyrate-producing bacteria and decrease lipopolysaccharide-producing bacteria. Hence, there is a need to have a personalized diet to manage the glucose level by enriching beneficial gut microbiota. The approach of a personalized diet associated with gut microbiota can be helpful in maintaining blood sugar in T2D patients.

摘要

背景

在过去几十年中,2型糖尿病(T2D)在全球的患病率大幅上升。在印度,无论地区、地位和年龄,糖尿病的流行都在持续增加。尽管有各种科学学会参与糖尿病的治疗,但糖尿病的负担仍在不断加重。

目的

本研究旨在探索阿育吠陀个性化饮食概念,通过调节肠道微生物群来治疗T2D。

材料与方法

对包括科学网、PubMed、Scopus和谷歌学术在内的在线科学数据库以及阿育吠陀经典文献进行了全面研究。精心汇编以提取个性化饮食调节肠道微生物群的有价值成果。

结果

有多种饮食用于控制血糖水平,尽管人类之间的基因组相似度为99.9%,但它们对转录组或表观基因组的影响也在研究中。然而,微生物组之间只有10%的相似度。阿育吠陀饮食是根据体质给出的,因此也被称为个性化饮食。

结论

阿育吠陀中为T2D规定的饮食富含纤维、多酚和复合碳水化合物,可丰富产生丁酸盐的细菌并减少产生脂多糖的细菌。因此,需要通过丰富有益的肠道微生物群来采用个性化饮食来控制血糖水平。与肠道微生物群相关的个性化饮食方法可能有助于维持T2D患者的血糖水平。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/10468021/b6d04880c7fe/AYU-43-35-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/10468021/a2b5529e67c7/AYU-43-35-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/10468021/b6d04880c7fe/AYU-43-35-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/10468021/a2b5529e67c7/AYU-43-35-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d2e3/10468021/b6d04880c7fe/AYU-43-35-g002.jpg

相似文献

1
Modulation of gut microbiota with Ayurveda diet and lifestyle: A review on its possible way to treat type 2 diabetes.阿育吠陀饮食与生活方式对肠道微生物群的调节作用:关于其治疗2型糖尿病可能途径的综述
Ayu. 2022 Apr-Jun;43(2):35-44. doi: 10.4103/ayu.AYU_7_20. Epub 2023 Aug 2.
2
Understanding the association between the human gut, oral and skin microbiome and the Ayurvedic concept of prakriti.了解人类肠道、口腔和皮肤微生物组与阿育吠陀概念 prakriti 之间的关联。
J Biosci. 2019 Oct;44(5).
3
Prakriti phenotypes as a stratifier of gut microbiome: A new frontier in personalized medicine?体质表型作为肠道微生物群的分层因素:个性化医疗的新前沿?
J Ayurveda Integr Med. 2020 Jul-Sep;11(3):360-365. doi: 10.1016/j.jaim.2020.05.013. Epub 2020 Jul 25.
4
Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet.通过长寿全食疗法的麻芪二方饮食调节2型糖尿病患者肠道微生物群失调
Br J Nutr. 2016 Jul;116(1):80-93. doi: 10.1017/S0007114516001045. Epub 2016 May 6.
5
Fecal Transplantation from db/db Mice Treated with Sodium Butyrate Attenuates Ischemic Stroke Injury.丁酸钠处理的 db/db 小鼠粪菌移植可减轻缺血性脑卒中损伤。
Microbiol Spectr. 2021 Oct 31;9(2):e0004221. doi: 10.1128/Spectrum.00042-21. Epub 2021 Oct 6.
6
An Ayurgenomics Approach: Prakriti-Based Drug Discovery and Development for Personalized Care.一种阿育吠陀基因组学方法:基于体质的个性化医疗药物发现与开发。
Front Pharmacol. 2022 Apr 1;13:866827. doi: 10.3389/fphar.2022.866827. eCollection 2022.
7
Western Indian Rural Gut Microbial Diversity in Extreme Endo-Phenotypes Reveals Signature Microbes.极端内表型下的西印度农村肠道微生物多样性揭示了标志性微生物。
Front Microbiol. 2018 Feb 13;9:118. doi: 10.3389/fmicb.2018.00118. eCollection 2018.
8
An 'Ayurveda-Biology' platform for integrative diabetes management.基于阿育吠陀-生物学的糖尿病综合管理平台。
J Ethnopharmacol. 2021 Mar 25;268:113575. doi: 10.1016/j.jep.2020.113575. Epub 2020 Nov 9.
9
Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India.丹麦和印度的跨种族 2 型糖尿病肠道微生物群特征。
Genome Med. 2021 Mar 3;13(1):37. doi: 10.1186/s13073-021-00856-4.
10
A Diet-Dependent Microbiota Profile Associated with Incident Type 2 Diabetes: From the CORDIOPREV Study.与2型糖尿病发病相关的饮食依赖性微生物群特征:来自CORDIOPREV研究
Mol Nutr Food Res. 2020 Dec;64(23):e2000730. doi: 10.1002/mnfr.202000730. Epub 2020 Oct 29.

引用本文的文献

1
Elucidating the Intricate Roles of Gut and Breast Microbiomes in Breast Cancer Metastasis to the Bone.阐明肠道和乳腺微生物组在乳腺癌骨转移中的复杂作用。
Cancer Rep (Hoboken). 2024 Aug;7(8):e70005. doi: 10.1002/cnr2.70005.

本文引用的文献

1
Ancient Diet: Gut Microbiota, Immunity, and Health.古代饮食:肠道微生物群、免疫力与健康。
Yale J Biol Med. 2018 Jun 28;91(2):177-184. eCollection 2018 Jun.
2
Western Indian Rural Gut Microbial Diversity in Extreme Endo-Phenotypes Reveals Signature Microbes.极端内表型下的西印度农村肠道微生物多样性揭示了标志性微生物。
Front Microbiol. 2018 Feb 13;9:118. doi: 10.3389/fmicb.2018.00118. eCollection 2018.
3
Towards utilization of the human genome and microbiome for personalized nutrition.为实现个性化营养,利用人类基因组和微生物组。
Curr Opin Biotechnol. 2018 Jun;51:57-63. doi: 10.1016/j.copbio.2017.11.013. Epub 2017 Dec 7.
4
The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.肠道微生物群作为2型糖尿病高血糖预防和治疗的靶点:从当前的人类证据到未来的可能性
Diabetologia. 2017 Jun;60(6):943-951. doi: 10.1007/s00125-017-4278-3. Epub 2017 Apr 22.
5
Ayurvedic concept of Shatkriyakala: a traditional knowledge of cancer pathogenesis and therapy.阿育吠陀医学的“六种治疗时机”概念:癌症发病机制与治疗的传统知识。
J Integr Med. 2017 Mar;15(2):88-94. doi: 10.1016/S2095-4964(17)60311-X.
6
Human gut microbes impact host serum metabolome and insulin sensitivity.人体肠道微生物影响宿主血清代谢组和胰岛素敏感性。
Nature. 2016 Jul 21;535(7612):376-81. doi: 10.1038/nature18646. Epub 2016 Jul 13.
7
Gut Microbiota in Type 2 Diabetes Individuals and Correlation with Monocyte Chemoattractant Protein1 and Interferon Gamma from Patients Attending a Tertiary Care Centre in Chennai, India.印度钦奈一家三级医疗中心2型糖尿病患者的肠道微生物群及其与单核细胞趋化蛋白1和干扰素γ的相关性
Indian J Endocrinol Metab. 2016 Jul-Aug;20(4):523-30. doi: 10.4103/2230-8210.183474.
8
Milk sphingomyelin improves lipid metabolism and alters gut microbiota in high fat diet-fed mice.乳鞘磷脂可改善高脂饮食喂养小鼠的脂质代谢并改变其肠道微生物群。
J Nutr Biochem. 2016 Apr;30:93-101. doi: 10.1016/j.jnutbio.2015.12.003. Epub 2016 Jan 4.
9
Sub-clinical detection of gut microbial biomarkers of obesity and type 2 diabetes.肥胖和2型糖尿病肠道微生物生物标志物的亚临床检测
Genome Med. 2016 Feb 17;8(1):17. doi: 10.1186/s13073-016-0271-6.
10
Rising risk of type 2 diabetes among inhabitants of Jamnagar, Gujarat: A cross-sectional survey.古吉拉特邦贾姆讷格尔居民2型糖尿病风险上升:一项横断面调查。
Ayu. 2015 Jan-Mar;36(1):10-7. doi: 10.4103/0974-8520.169014.